HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chad G Rusthoven Selected Research

Chad G Rusthoven Research Topics

Disease

29Neoplasms (Cancer)
04/2024 - 01/2014
23Brain Neoplasms (Brain Tumor)
05/2024 - 11/2017
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 07/2015
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 01/2017
10Lung Neoplasms (Lung Cancer)
04/2024 - 11/2015
8Prostatic Neoplasms (Prostate Cancer)
04/2016 - 04/2014
6Neoplasm Metastasis (Metastasis)
01/2023 - 01/2014
5Melanoma (Melanoma, Malignant)
05/2024 - 12/2017
4Glioblastoma (Glioblastoma Multiforme)
01/2020 - 11/2014
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 01/2014
3Glioma (Gliomas)
05/2021 - 11/2014
2Renal Cell Carcinoma (Grawitz Tumor)
07/2023 - 01/2022
2Breast Neoplasms (Breast Cancer)
01/2019 - 01/2018
2Margins of Excision
11/2018 - 01/2017
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2016 - 01/2016
1Central Nervous System Diseases (CNS Diseases)
01/2023
1Necrosis
01/2023
1Pneumonia (Pneumonitis)
01/2022
1Neurologic Manifestations (Neurological Manifestations)
01/2022
1Radiation Pneumonitis
01/2022
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2018
1Stomach Neoplasms (Stomach Cancer)
09/2017
1Adenocarcinoma
09/2017
1Squamous Cell Carcinoma of Head and Neck
01/2017
1Thymoma (Thymic Carcinoma)
01/2017
1Nasopharyngeal Carcinoma
01/2017
1Cholangiocarcinoma
07/2016
1Neurofibrosarcoma (MPNST)
06/2015
1Oligodendroglioma
11/2014
1Astrocytoma (Pilocytic Astrocytoma)
11/2014

Drug/Important Bio-Agent (IBA)

6Immune Checkpoint InhibitorsIBA
10/2023 - 10/2018
4AndrogensIBA
04/2016 - 01/2016
4Prostate-Specific Antigen (Semenogelase)IBA
04/2016 - 04/2014
2Tyrosine Kinase InhibitorsIBA
01/2023 - 01/2022
2Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2017
2Temozolomide (Temodar)FDA LinkGeneric
01/2017 - 01/2016
1durvalumabIBA
01/2023
1Memantine (Namenda)FDA Link
07/2022
1SteroidsIBA
01/2022
1SRS-AIBA
11/2020
1Ado-Trastuzumab EmtansineIBA
01/2019
1Anaplastic Lymphoma KinaseIBA
01/2018
1boldenone undecylenate (Equipoise)IBA
12/2017
13-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA
01/2017
1Rituximab (Mabthera)FDA Link
05/2016
1Bevacizumab (Avastin)FDA Link
01/2014

Therapy/Procedure

48Radiotherapy
04/2024 - 01/2014
19Therapeutics
05/2024 - 01/2014
10Drug Therapy (Chemotherapy)
01/2022 - 01/2014
8Cranial Irradiation
01/2022 - 01/2017
3Immunotherapy
05/2021 - 12/2017
3Chemoradiotherapy
01/2019 - 01/2017
3Combined Modality Therapy
07/2016 - 01/2016
2Adjuvant Chemotherapy
06/2019 - 01/2019
2Adjuvant Radiotherapy
09/2017 - 06/2015
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2017 - 05/2016
1Aftercare (After-Treatment)
01/2023
1Time-to-Treatment
01/2021
1Radioimmunotherapy
01/2019
1Neoadjuvant Therapy
01/2019
1Hysterectomy
01/2019
1Segmental Mastectomy (Lumpectomy)
01/2018
1Re-Irradiation
01/2018
1Retreatment
01/2018
1Adjuvant Chemoradiotherapy
09/2017
1Gastrectomy
09/2017
1Brachytherapy
03/2016
1Lymph Node Excision (Lymph Node Dissection)
07/2015
1Prostatectomy (Retropubic Prostatectomy)
04/2014